EUVIMEDEUVIMED entdecken
Leserbrief

Hyperinsulinism‐induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)‐rywn chemotherapy in a pediatric AML patient

Ashley Carlo, Ally Watson, Genna Klein, Steven Ghanny, Shoshana Tell, Tamar Horowitz, Molly Siver, Burton Appel, Jing Chen

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.30914 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Ashley Carlo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology/Oncology, Hackensack University Medical Center, Hackensack, New Jersey, USA. Hauptthemen laut MEDLINE: Dickeya chrysanthemi, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Erwinia, Leukemia, Myeloid, Acute. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dickeya chrysanthemiPrecursor Cell Lymphoblastic Leukemia-LymphomaErwiniaLeukemia, Myeloid, AcuteAntineoplastic AgentsChildHumansAsparaginase

Substanzen

AsparaginaseAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pediatric Hematology/Oncology, Hackensack University Medical Center, Hackensack, New Jersey, USA.
  • Department of Pediatrics, Hackensack University Medical Center, Hackensack, New Jersey, USA.
  • Department of Pediatric Endocrinology, Hackensack University Medical Center, Hackensack, New Jersey, USA.
  • Department of Pharmacy, Hackensack University Medical Center, Hackensack, New Jersey, USA.

Zitieren

APA

Carlo, A., Watson, A., Klein, G., Ghanny, S., Tell, S., Horowitz, T., Siver, M., Appel, B., & Chen, J. (2024). Hyperinsulinism‐induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)‐rywn chemotherapy in a pediatric AML patient. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30914

Vancouver

Carlo A, Watson A, Klein G, Ghanny S, Tell S, Horowitz T, et al. Hyperinsulinism‐induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)‐rywn chemotherapy in a pediatric AML patient. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30914

BibTeX
@article{Carlo2024,
  author = {Carlo, Ashley and Watson, Ally and Klein, Genna and Ghanny, Steven and Tell, Shoshana and Horowitz, Tamar and Siver, Molly and Appel, Burton and Chen, Jing},
  title = {Hyperinsulinism‐induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)‐rywn chemotherapy in a pediatric AML patient},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.30914}
}
Kostenlos starten →